net dbt
miss guidanc cut growth
organ growth disappoint unexpect area
result came street expect organ revenu
growth estim lower volum forecast
volum vs report price ahead forecast
investor concern focus automot health
safeti graphic drove miss na emea organ volum
respect unexpect area weak compani note last quarter
pull-forward revenu back erp roll-out
expect current strong short-cycl environ growth forecast
still conserv compani cut ep outlook year fx
drag vs benefit prior lower organ growth vs prior
lower convers target silver line
could ep cut also reset expect ahead expect
construct analyst meet novemb therefor reiter buy rate
op miss top line margin
mmm ep came estim consensu
rel model segment op miss beat
electron stronger top line organ vs estimate flat y/i margin
vs estimate off-set miss segment safeti graphic
miss weaker margin vs estimate industri
miss margin well vs estimate health also
miss organ top line declin vs estimate consum
drag weaker top line organ vs estimate better corpor
boost higher share count interest expens drag
ep outlook cut organ growth
lower adj ep outlook
old estimate consensu cut organ top-lin forecast
ep expect come rang
old estimate consensu guidanc updat includ
announc fx headwind year alreadi includ
model lower estim miss may review model call
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
compani found mine
concern today minnesota-bas compani
diversifi global manufactur busi
technology-driven organ five
segment consum safeti graphic
electron health industri
popular brand includ scotch post-it
thinsul hold us patent
lower cyclic high-return portfolio
view posit investor current
compani well diversifi across end
market geographi
defens less cyclic busi model
focus shorter cycl product stock
defens tend outperform peer
market recess
chart revenu break-out segment
us mn except per share data
corpor unalloc
elimin dual credit
corpor unalloc
elimin dual credit
net incom attribut non-controlling interest
tabl price growth y/i region
tabl organ growth segment geographi
hc healthcar safeti graphic electron
chart industri organ total y/i revenu growth
chart safeti graphic organ total y/i revenu growth
chart electron organ total y/i revenu growth
chart consum organ total y/i revenu growth
chart health organ total y/i revenu growth
chart total organ total y/i revenu growth
po base price-to-earnings slight premium premium
consum good peer trade translat ev/ebitda
growth return characterist histor line high-qual
consum name industri cyclic believ trade
premium multi-industri peer line premium consum good
peer reflect superior growth return
downsid risk po compani larg global emerg market
exposur need greater invest could margin headwind slower-
andrew obin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us multi-industrials/engin construct coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
